IO Biotech, Inc. (IOBTQ) Operating Expenses (2020 - 2025)

IO Biotech's (IOBTQ) quarterly Operating Expenses came in at $886000.0 in Q3 2025, up 250.2% on a QoQ basis from $253000.0 in Q2 2025.

IO Biotech, Inc. (IOBTQ) Operating Expenses (2020 - 2025) Analysis & Trends

IO Biotech (IOBTQ) has 6 years of Operating Expenses data on file, last reported at $886000.0 in Q3 2025.

Quarterly Operating Expenses changed N/A year-over-year to $886000.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $50.7 million (up 4.73% YoY) and the FY2024 annual result came in at $95.2 million, up 4.08% from the prior year.
Operating Expenses climbed to $886000.0 in Q3 2025, from $253000.0 in the prior quarter.
In the past five years, Operating Expenses ranged from a high of $28.2 million in Q4 2023 to a low of $253000.0 in Q2 2025.
A 5-year average of $16.2 million and a median of $18.2 million in 2022 frame the typical range for Operating Expenses.
Annual changes were most pronounced in 2021 — Operating Expenses jumped 742.65% — and 2022, when it declined 4.7%.
Tracing IOBTQ's Operating Expenses over 5 years: stood at $21.4 million in 2021, then slipped by 4.7% to $20.4 million in 2022, then surged by 38.23% to $28.2 million in 2023, then decreased by 4.4% to $26.9 million in 2024, then tumbled by 96.71% to $886000.0 in 2025.
The last three Operating Expenses figures came in at $886000.0 (Q3 2025), $253000.0 (Q2 2025), and $22.6 million (Q1 2025), per Business Quant data.

Download Data